Mif belongs to both GO: 0002683 and GO: 0071456 [48] and mediates both immunosuppression and inflammation and has been associated with increased tumorigenesis and disease progression in different cancer types including prostate cancer [66]. Here, MIF is linked to prostate carcinoma.